REQUEST A DEMO
Total
USD $0.00
Search more companies

Matrix Therapeutics Private Limited. (India)

Main Activities: Basic Chemical Manufacturing
Full name: Matrix Therapeutics Private Limited. Profile Updated: August 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Matrix Therapeutics Private Limited. is a company in India, with a head office in Rangareddy. It operates in the Basic Chemical Manufacturing industry. The enterprise was incorporated on October 28, 2005. The latest financial highlights indicate a net sales revenue increase of 16.3% in 2025. During that time, Matrix Therapeutics Private Limited.’s total assets grew by 4.25%. The net profit margin of Matrix Therapeutics Private Limited. decreased by 0.93% in 2025.

Headquarters
Plot No. 15 2Nd Floor Survey No. 40 41 Kavuri Hills Guttala Begumpet Village Serilingampally Mandal Rangareddi Hyderabad In-Ts In 500019
Rangareddy; Andhra Pradesh; Postal Code: 500019

Contact Details: Purchase the Matrix Therapeutics Private Limited. report to view the information.

Basic Information
Registered Capital:
Purchase the Matrix Therapeutics Private Limited. report to view the information.
Financial Auditors:
Purchase the Matrix Therapeutics Private Limited. report to view the information.
Incorporation Date:
October 28, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Additional Executive Director
Company Performance
Financial values in the chart are available after Matrix Therapeutics Private Limited. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
16.3%
Total Operating Revenue
16.22%
Operating Profit
7.64%
EBITDA
6.24%
Net Profit/Loss for the Period
-4.25%
Total Assets
4.25%
Total Equity
14.34%
Operating Profit Margin
-0.59%
Net Profit Margin
-0.93%
Return on Equity (ROE)
-2.44%
Debt / Equity
-6.55%
Quick Ratio
0.09%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?